{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:30:30Z","timestamp":1785306630439,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04511-5","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T13:44:59Z","timestamp":1767015899000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of Goserelin acetate on non-invasive indices of hepatic steatosis in women with endometriosis"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8621-7478","authenticated-orcid":false,"given":"Dimitrios A.","family":"Anastasilakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios D.","family":"Anastasilakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina","family":"Gkiomisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Semertzidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Nikolakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stergios","family":"Papachatzopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelos","family":"Daniilidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios G.","family":"Goulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis","family":"Goulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"4511_CR1","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"M.E. Rinella, J.V. Lazarus, V. Ratziu, S.M. Francque, A.J. Sanyal, F. Kanwal, D. Romero, M.F. Abdelmalek, Q.M. Anstee, J.P. Arab, M. Arrese, R. Bataller, U. Beuers, J. Boursier, E. Bugianesi, C.D. Byrne, G.E. Castro Narro, A. Chowdhury, H. Cortez-Pinto, D.R. Cryer, K. Cusi, M. El-Kassas, S. Klein, W. Eskridge, J. Fan, S. Gawrieh, C.D. Guy, S.A. Harrison, S.U. Kim, B.G. Koot, M. Korenjak, K.V. Kowdley, F. Lacaille, R. Loomba, R. Mitchell-Thain, T.R. Morgan, E.E. Powell, M. Roden, M. Romero-Gomez, M. Silva, S.P. Singh, S.C. Sookoian, C.W. Spearman, D. Tiniakos, L. Valenti, M.B. Vos, V.W. Wong, S. Xanthakos, Y. Yilmaz, Z. Younossi, A. Hobbs, Villota-Rivas, P.N. Newsome, N.N.c. group, A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 78, 1966\u20131986 (2023)","journal-title":"Hepatology"},{"key":"4511_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.arcmed.2020.11.010","volume":"52","author":"E Makri","year":"2021","unstructured":"E. Makri, A. Goulas, S.A. Polyzos, Epidemiology, Pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease. Arch. Med. Res. 52, 25\u201337 (2021)","journal-title":"Arch. Med. Res."},{"key":"4511_CR3","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1111\/dom.16117","volume":"27","author":"SA Polyzos","year":"2025","unstructured":"S.A. Polyzos, G. Targher, Hepatic thyroid hormone receptor-beta signalling: mechanisms and recent advancements in the treatment of metabolic dysfunction-associated steatohepatitis. Diabetes Obes. Metab. 27, 1635\u20131647 (2025)","journal-title":"Diabetes Obes. Metab."},{"key":"4511_CR4","doi-asserted-by":"publisher","first-page":"155936","DOI":"10.1016\/j.metabol.2024.155936","volume":"157","author":"SA Polyzos","year":"2024","unstructured":"S.A. Polyzos, C.S. Mantzoros, Metabolic dysfunction-associated steatotic liver disease: recent turning points for its diagnosis and management. Metabolism. 157, 155936 (2024)","journal-title":"Metabolism"},{"key":"4511_CR5","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","volume":"392","author":"AJ Sanyal","year":"2025","unstructured":"A.J. Sanyal, P.N. Newsome, I. Kliers, L.H. Ostergaard, M.T. Long, M.S. Kjaer, A.M.G. Cali, E. Bugianesi, M.E. Rinella, M. Roden, V. Ratziu, E.S. Group, Phase 3 trial of semaglutide in metabolic Dysfunction-Associated steatohepatitis. N Engl. J. Med. 392, 2089\u20132099 (2025)","journal-title":"N Engl. J. Med."},{"key":"4511_CR6","first-page":"127","volume":"13","author":"S.A. Polyzos","year":"2009","unstructured":"S.A. Polyzos, J. Kountouras, C. Zavos. The multi-hit process and the antagonistic roles of tumor necrosis factor-alpha and adiponectin in non alcoholic fatty liver disease. Hippokratia. 13, 127; author reply 128 (2009)","journal-title":"Hippokratia"},{"key":"4511_CR7","doi-asserted-by":"publisher","first-page":"108024","DOI":"10.1016\/j.maturitas.2024.108024","volume":"186","author":"SA Polyzos","year":"2024","unstructured":"S.A. Polyzos, D.G. Goulis, Menopause and metabolic dysfunction-associated steatotic liver disease. Maturitas. 186, 108024 (2024)","journal-title":"Maturitas"},{"key":"4511_CR8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/GME.0000000000002133","volume":"30","author":"A Jaroenlapnopparat","year":"2023","unstructured":"A. Jaroenlapnopparat, N. Charoenngam, B. Ponvilawan, M. Mariano, J. Thongpiya, P. Yingchoncharoen, Menopause is associated with increased prevalence of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Menopause. 30, 348\u2013354 (2023)","journal-title":"Menopause"},{"key":"4511_CR9","doi-asserted-by":"publisher","first-page":"E363","DOI":"10.1503\/cmaj.220637","volume":"195","author":"C Allaire","year":"2023","unstructured":"C. Allaire, M.A. Bedaiwy, P.J. Yong, Diagnosis and management of endometriosis. CMAJ. 195, E363\u2013E371 (2023)","journal-title":"CMAJ"},{"key":"4511_CR10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/humrep\/det457","volume":"29","author":"GA Dunselman","year":"2014","unstructured":"G.A. Dunselman, N. Vermeulen, C. Becker, C. Calhaz-Jorge, T. D\u2019Hooghe, B. De Bie, O. Heikinheimo, A.W. Horne, L. Kiesel, A. Nap, A. Prentice, E. Saridogan, D. Soriano, W. Nelen, European society of Human, Embryology, ESHRE guideline: management of women with endometriosis. Hum. Reprod. 29, 400\u2013412 (2014)","journal-title":"Hum. Reprod."},{"key":"4511_CR11","doi-asserted-by":"publisher","first-page":"116354","DOI":"10.1016\/j.bone.2022.116354","volume":"158","author":"AD Anastasilakis","year":"2022","unstructured":"A.D. Anastasilakis, S. Papachatzopoulos, P. Makras, A. Gkiomisi, P. Nikolakopoulos, S.A. Polyzos, C. Ntenti, I. Ballaouri, S. Gerou, O. Tsachouridou, A. Papatheodorou, K. Aliazis, S. Fermanoglou, I. Bisbinas, M.P. Yavropoulou, The effect of Pharmacological cessation and restoration of menstrual cycle on bone metabolism in premenopausal women with endometriosis. Bone. 158, 116354 (2022)","journal-title":"Bone"},{"key":"4511_CR12","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/jcph.485","volume":"55","author":"L Gong","year":"2015","unstructured":"L. Gong, S. Zhang, Y. Han, Q. Long, S. Zou, Y. Cao, Initiation of GnRH agonist treatment on 3\u20135 days postoperatively in endometriosis patients: a randomized controlled trial. J. Clin. Pharmacol. 55, 848\u2013853 (2015)","journal-title":"J. Clin. Pharmacol."},{"key":"4511_CR13","doi-asserted-by":"publisher","first-page":"5430","DOI":"10.3390\/jcm12165430","volume":"12","author":"A.D. Anastasilakis","year":"2023","unstructured":"A.D. Anastasilakis, S.A. Polyzos, P.A. Vorkas, A. Gkiomisi, M.P. Yavropoulou, M. Rauner, P. Nikolakopoulos, S. Papachatzopoulos, P. Makras, S. Gerou, L.C. Hofbauer, A. Palermo, E. Tsourdi, Lipid profile after Pharmacologic discontinuation and restoration of menstruation in women with endometriosis: A 12-Month observational prospective study. J. Clin. Med. 12, 5430 (2023)","journal-title":"J. Clin. Med."},{"key":"4511_CR14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"J.H. Lee, D. Kim, H.J. Kim, C.H. Lee, J.I. Yang, W. Kim, Y.J. Kim, J.H. Yoon, S.H. Cho, M.W. Sung, H.S. Lee, Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig. Liver Dis. 42, 503\u2013508 (2010)","journal-title":"Dig. Liver Dis."},{"key":"4511_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12944-017-0409-6","volume":"16","author":"S Zhang","year":"2017","unstructured":"S. Zhang, T. Du, J. Zhang, H. Lu, X. Lin, J. Xie, Y. Yang, X. Yu, The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids Health Dis. 16, 15 (2017)","journal-title":"Lipids Health Dis."},{"key":"4511_CR16","doi-asserted-by":"publisher","first-page":"e7041","DOI":"10.1097\/MD.0000000000007041","volume":"96","author":"S. Zhang","year":"2017","unstructured":"S. Zhang, T. Du, M. Li, J. Jia, H. Lu, X. Lin, X. Yu. Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects. Medicine (Baltimore). 96, e7041 (2017)","journal-title":"Medicine (Baltimore)"},{"key":"4511_CR17","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/liv.12977","volume":"36","author":"Y Fukuda","year":"2016","unstructured":"Y. Fukuda, Y. Hashimoto, M. Hamaguchi, T. Fukuda, N. Nakamura, A. Ohbora, T. Kato, T. Kojima, M. Fukui, Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study. Liver Int. 36, 713\u2013720 (2016)","journal-title":"Liver Int."},{"key":"4511_CR18","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3350\/cmh.2022.0099","volume":"28","author":"JH Lee","year":"2022","unstructured":"J.H. Lee, K. Park, H.S. Lee, H.K. Park, J.H. Han, S.B. Ahn, The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults. Clin. Mol. Hepatol. 28, 814\u2013826 (2022)","journal-title":"Clin. Mol. Hepatol."},{"key":"4511_CR19","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/j.cgh.2020.01.020","volume":"18","author":"S McHenry","year":"2020","unstructured":"S. McHenry, Y. Park, J.D. Browning, G. Sayuk, N.O. Davidson, Dallas steatosis index identifies patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 18, 2073\u20132080 (2020)","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"4511_CR20","doi-asserted-by":"crossref","unstructured":"M.T. Long, A. Pedley, L.D. Colantonio, J.M. Massaro, U. Hoffmann, P. Muntner, C.S. Fox. Development and Validation of the Framingham Steatosis Index to Identify Persons With Hepatic Steatosis. Clin Gastroenterol Hepatol. 14, 1172\u20131180 e1172 (2016)","DOI":"10.1016\/j.cgh.2016.03.034"},{"key":"4511_CR21","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/gut.2007.146019","volume":"57","author":"SA Harrison","year":"2008","unstructured":"S.A. Harrison, D. Oliver, H.L. Arnold, S. Gogia, B.A. Neuschwander-Tetri, Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 57, 1441\u20131447 (2008)","journal-title":"Gut"},{"key":"4511_CR22","doi-asserted-by":"publisher","first-page":"e014","DOI":"10.1097\/PG9.0000000000000014","volume":"1","author":"Y. Sasaki","year":"2020","unstructured":"Y. Sasaki, H. Kajino, H. Gotoda, A case of nonalcoholic steatohepatitis in central precocious puberty aggravated by Gonadotropin-releasing hormone analog. JPGN Rep. 1, e014 (2020)","journal-title":"JPGN Rep."},{"key":"4511_CR23","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.juro.2018.03.135","volume":"200","author":"P Gild","year":"2018","unstructured":"P. Gild, A.P. Cole, A. Krasnova, B.A. Dickerman, N. von Landenberg, M. Sun, L.A. Mucci, S.R. Lipsitz, F.K. Chun, P.L. Nguyen, A.S. Kibel, T.K. Choueiri, S. Basaria, Q.D. Trinh, Liver disease in men undergoing androgen deprivation therapy for prostate cancer. J. Urol. 200, 573\u2013581 (2018)","journal-title":"J. Urol."},{"key":"4511_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/01.mcg.0000225583.32588.5e","volume":"42","author":"C Gabbi","year":"2008","unstructured":"C. Gabbi, F. Carubbi, L. Losi, P. Loria, M. Costantini, M. Bertolotti, N. Carulli, Nonalcoholic fatty liver disease induced by leuprorelin acetate. J. Clin. Gastroenterol. 42, 107\u2013110 (2008)","journal-title":"J. Clin. Gastroenterol."},{"key":"4511_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1159\/000507351","volume":"104","author":"H Sawazaki","year":"2020","unstructured":"H. Sawazaki, Y. Kitamura, K. Yagi, Y. Arai, Impact of androgen deprivation therapy on Non-Alcoholic fatty liver disease in patients with prostate cancer: A CT evaluation. Urol. Int. 104, 425\u2013430 (2020)","journal-title":"Urol. Int."},{"key":"4511_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12958-025-01391-2","volume":"23","author":"H Huang","year":"2025","unstructured":"H. Huang, Z. Liu, J. Ruan, Z. Fang, C. Xu, Laparoscopically confirmed endometriosis and the risk of incident NAFLD: a prospective cohort study. Reprod. Biol. Endocrinol. 23, 55 (2025)","journal-title":"Reprod. Biol. Endocrinol."},{"key":"4511_CR27","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3390\/jpm12071166","volume":"12","author":"ES Makri","year":"2022","unstructured":"E.S. Makri, E. Makri, S.A. Polyzos, Combination therapies for nonalcoholic fatty liver disease. J. Pers. Med. 12, 1166 (2022)","journal-title":"J. Pers. Med."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04511-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04511-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04511-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T02:03:34Z","timestamp":1767060214000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04511-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4511"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04511-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7566446\/v1","asserted-by":"object"}]},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of the 424 General Military Hospital (16329\/04-09-2018). All procedures performed in the study were in accordance with the ethical standards of the institutional research committees and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was retrospectively obtained from all participants for the use of their data for the purpose of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"12"}}